author-photo

Jens Atzpodien

Hochschule Hannover

158

Papers

4908

Citations

Citation Trend

Filter By

Papers (158) Sort By

JournalConferenceOthers

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

2021 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (14)
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109).

2020 Journal of Cancer Research and Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status: Analysis of untreated RAS-wildtype mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Effects of Implementing a Brief Family Nursing Intervention With Hospitalized Oncology Patients and Their Families in Germany: A Quasi-Experimental Study.

2020 Journal of Family Nursing
Show All
- Source
- Cite
- Save
Citations (2)
FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109)

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (68)
Tumor dynamics with fluorouracil/folinic acid, irinotecan, and oxaliplatin (FOLFOXIRI) plus panitumumab (pmab) or FOLFOXIRI alone as initial treatment of RAS wildtype metastatic colorectal cancer (mCRC): Central radiologic review of VOLFI—A randomized, open label, phase-2 study (AIO KRK0109).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Prognostic Gene Signature Expressed in Primary Cutaneous Melanoma: Synergism With Conventional Staging

2018 JNCI Cancer Spectrum
Show All
- Source
- Cite
- Save
Citations (13)
Abstract 2861: Independent validation of a prognostic gene-signature based risk score in formalin-fixed paraffin-embedded melanomas

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
A nine-gene signature predicting clinical outcome in cutaneous melanoma

2013 Journal of Cancer Research and Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (49)
Validation of a fresh-frozen tissue based prognostic gene signature in formalin-fixed, paraffin-embedded melanomas

2011 Journal Der Deutschen Dermatologischen Gesellschaft
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号